Soy isoflavones alter expression of genes associated with cancer progression, including interleukin-8, in androgen-independent PC-3 human prostate cancer cells

被引:47
作者
Handayani, R
Rice, L [1 ]
Cui, YH
Medrano, TA
Samedi, VG
Baker, HV
Szabo, NJ
Shiverick, KT
机构
[1] Univ Florida, Coll Med, Dept Surg, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Med, Dept Therapeut & Pharmacol, Gainesville, FL 32610 USA
[3] Univ Florida, Coll Med, Dept Microbiol & Mol Genet, Gainesville, FL 32610 USA
[4] Univ Florida, Coll Vet Med, Analyt Toxicol Core Lab, Gainesville, FL 32610 USA
[5] Univ Florida, Coll Liberal Arts & Sci, Dept Stat, Gainesville, FL 32610 USA
关键词
interleukin-8; isoflavones; microarray; p21(CIP1); prostate;
D O I
10.1093/jn/136.1.75
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
High consumption of soy isoflavones in Asian diets has been correlated with a lower incidence of clinically important cases of prostate cancer. The chemopreventive properties of these diets may result from an interaction of several types of isoflavones, including genistein and daidzein. The present study investigated the effects of a soy isoflavone concentrate (ISF) on growth and gene expression profiles of PC-3 human prostate cancer cells. Trypan blue exclusion and [H-3]-thymidine incorporation assays showed that ISF decreased cell viability and caused a dose-dependent inhibition of DNA synthesis, respectively, with 50% inhibition (IC50) of DNA synthesis at 52 mg/L (P = 0.05). The glucoside conjugates of genistein and daidzein in ISF were converted to bioactive free aglycones in cell culture in association with the inhibition of DNA synthesis. Flow cytometry and Western immunoblot analyses showed that ISF at 200 mg/L caused an accumulation of cells in the G(2)/M phase of the cell cycle (P < 0.05) and decreased cyclin A by 20% (P < 0.05), respectively. The effect of ISF on the gene expression profile of PC-3 cells was analyzed using Affymetrix oligonucleotide DNA microarrays that interrogate similar to 17,000 human genes. Of the 75 genes altered by ISF, 28 were upregulated and 47 were downregulated (P < 0.05). Further analysis showed that IL-8, matrix metalloproteinase 13, inhibin 6 A, follistatin, and fibronectin mRNA levels were significantly reduced, whereas the expression of p21(CIP1), a major cell cycle inhibitory protein, was increased. The effects of ISF on the expression of IL-8 and p21(CIP1) mRNA and protein were validated at high and low ISF concentrations. Our data show that ISF inhibits the growth of PC-3 cells through modulation of cell cycle progression and the expression of genes involved in cell cycle regulation, metastasis, and angiogenesis.
引用
收藏
页码:75 / 82
页数:8
相关论文
共 41 条
[1]  
ADLERCREUTZ CHT, 1995, J NUTR, V125, pS757, DOI 10.1093/jn/125.3_Suppl.757S
[2]   PLASMA-CONCENTRATIONS OF PHYTO-ESTROGENS IN JAPANESE MEN [J].
ADLERCREUTZ, H ;
MARKKANEN, H ;
WATANABE, S .
LANCET, 1993, 342 (8881) :1209-1210
[3]  
BARNES S, 1995, J CELL BIOCHEM, P181
[4]   NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells [J].
Brar, SS ;
Corbin, Z ;
Kennedy, TP ;
Hemendinger, R ;
Thornton, L ;
Bommarius, B ;
Arnold, RS ;
Whorton, AR ;
Sturrock, AB ;
Huecksteadt, TP ;
Quinn, MT ;
Krenitsky, K ;
Ardie, KG ;
Lambeth, JD ;
Hoidal, JR .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 285 (02) :C353-C369
[5]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[6]   Analysis of plasma isoflavones by reversed-phase HPLC-multiple reaction ion monitoring-mass spectrometry [J].
Coward, L ;
Kirk, M ;
Albin, N ;
Barnes, S .
CLINICA CHIMICA ACTA, 1996, 247 (1-2) :121-142
[7]   Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines [J].
Daja, MM ;
Niu, X ;
Zhao, Z ;
Brown, JM ;
Russell, PJ .
PROSTATE CANCER AND PROSTATIC DISEASES, 2003, 6 (01) :15-26
[8]   Soy isoflavone supplementation in healthy men prevents NF-κB activation by TNF-α in blood lymphocytes [J].
Davis, JN ;
Kucuk, O ;
Djuric, Z ;
Sarkar, FH .
FREE RADICAL BIOLOGY AND MEDICINE, 2001, 30 (11) :1293-1302
[9]  
EL DW, 1993, CELL, V75, P817
[10]  
ELSEN MB, 1998, P NATL ACAD SCI USA, V95, P14863